A genome-scale CRISPR Cas9 dropout screen identifies synthetically lethal targets in SRC-3 inhibited cancer cells

Using a CRISPR-based large-scale screen, Gilad et al. identify the genes that show synthetic lethality with an SRC-3 inhibitor in breast cancer cells while contrasting this with the estrogen receptor degrader fulvestrant. This study provides insights into the development of therapeutic strategies fo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yosi Gilad, Yossi Eliaz, Yang Yu, Adam M. Dean, San Jung Han, Li Qin, Bert W. O’Malley, David M. Lonard
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Acceso en línea:https://doaj.org/article/6fce305479b5409cbdcf3ff5d35853b8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6fce305479b5409cbdcf3ff5d35853b8
record_format dspace
spelling oai:doaj.org-article:6fce305479b5409cbdcf3ff5d35853b82021-12-02T11:44:59ZA genome-scale CRISPR Cas9 dropout screen identifies synthetically lethal targets in SRC-3 inhibited cancer cells10.1038/s42003-021-01929-12399-3642https://doaj.org/article/6fce305479b5409cbdcf3ff5d35853b82021-03-01T00:00:00Zhttps://doi.org/10.1038/s42003-021-01929-1https://doaj.org/toc/2399-3642Using a CRISPR-based large-scale screen, Gilad et al. identify the genes that show synthetic lethality with an SRC-3 inhibitor in breast cancer cells while contrasting this with the estrogen receptor degrader fulvestrant. This study provides insights into the development of therapeutic strategies for cancer forms that involve SRC-3.Yosi GiladYossi EliazYang YuAdam M. DeanSan Jung HanLi QinBert W. O’MalleyDavid M. LonardNature PortfolioarticleBiology (General)QH301-705.5ENCommunications Biology, Vol 4, Iss 1, Pp 1-17 (2021)
institution DOAJ
collection DOAJ
language EN
topic Biology (General)
QH301-705.5
spellingShingle Biology (General)
QH301-705.5
Yosi Gilad
Yossi Eliaz
Yang Yu
Adam M. Dean
San Jung Han
Li Qin
Bert W. O’Malley
David M. Lonard
A genome-scale CRISPR Cas9 dropout screen identifies synthetically lethal targets in SRC-3 inhibited cancer cells
description Using a CRISPR-based large-scale screen, Gilad et al. identify the genes that show synthetic lethality with an SRC-3 inhibitor in breast cancer cells while contrasting this with the estrogen receptor degrader fulvestrant. This study provides insights into the development of therapeutic strategies for cancer forms that involve SRC-3.
format article
author Yosi Gilad
Yossi Eliaz
Yang Yu
Adam M. Dean
San Jung Han
Li Qin
Bert W. O’Malley
David M. Lonard
author_facet Yosi Gilad
Yossi Eliaz
Yang Yu
Adam M. Dean
San Jung Han
Li Qin
Bert W. O’Malley
David M. Lonard
author_sort Yosi Gilad
title A genome-scale CRISPR Cas9 dropout screen identifies synthetically lethal targets in SRC-3 inhibited cancer cells
title_short A genome-scale CRISPR Cas9 dropout screen identifies synthetically lethal targets in SRC-3 inhibited cancer cells
title_full A genome-scale CRISPR Cas9 dropout screen identifies synthetically lethal targets in SRC-3 inhibited cancer cells
title_fullStr A genome-scale CRISPR Cas9 dropout screen identifies synthetically lethal targets in SRC-3 inhibited cancer cells
title_full_unstemmed A genome-scale CRISPR Cas9 dropout screen identifies synthetically lethal targets in SRC-3 inhibited cancer cells
title_sort genome-scale crispr cas9 dropout screen identifies synthetically lethal targets in src-3 inhibited cancer cells
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/6fce305479b5409cbdcf3ff5d35853b8
work_keys_str_mv AT yosigilad agenomescalecrisprcas9dropoutscreenidentifiessyntheticallylethaltargetsinsrc3inhibitedcancercells
AT yossieliaz agenomescalecrisprcas9dropoutscreenidentifiessyntheticallylethaltargetsinsrc3inhibitedcancercells
AT yangyu agenomescalecrisprcas9dropoutscreenidentifiessyntheticallylethaltargetsinsrc3inhibitedcancercells
AT adammdean agenomescalecrisprcas9dropoutscreenidentifiessyntheticallylethaltargetsinsrc3inhibitedcancercells
AT sanjunghan agenomescalecrisprcas9dropoutscreenidentifiessyntheticallylethaltargetsinsrc3inhibitedcancercells
AT liqin agenomescalecrisprcas9dropoutscreenidentifiessyntheticallylethaltargetsinsrc3inhibitedcancercells
AT bertwomalley agenomescalecrisprcas9dropoutscreenidentifiessyntheticallylethaltargetsinsrc3inhibitedcancercells
AT davidmlonard agenomescalecrisprcas9dropoutscreenidentifiessyntheticallylethaltargetsinsrc3inhibitedcancercells
AT yosigilad genomescalecrisprcas9dropoutscreenidentifiessyntheticallylethaltargetsinsrc3inhibitedcancercells
AT yossieliaz genomescalecrisprcas9dropoutscreenidentifiessyntheticallylethaltargetsinsrc3inhibitedcancercells
AT yangyu genomescalecrisprcas9dropoutscreenidentifiessyntheticallylethaltargetsinsrc3inhibitedcancercells
AT adammdean genomescalecrisprcas9dropoutscreenidentifiessyntheticallylethaltargetsinsrc3inhibitedcancercells
AT sanjunghan genomescalecrisprcas9dropoutscreenidentifiessyntheticallylethaltargetsinsrc3inhibitedcancercells
AT liqin genomescalecrisprcas9dropoutscreenidentifiessyntheticallylethaltargetsinsrc3inhibitedcancercells
AT bertwomalley genomescalecrisprcas9dropoutscreenidentifiessyntheticallylethaltargetsinsrc3inhibitedcancercells
AT davidmlonard genomescalecrisprcas9dropoutscreenidentifiessyntheticallylethaltargetsinsrc3inhibitedcancercells
_version_ 1718395287107534848